Brazil this month will start testing an experimental vaccine against the novel coronavirus being developed by researchers at the University of Oxford and AstraZeneca Plc (AZN.L), Brazil’s health surveillance agency Anvisa and the Federal University of Sao Paulo (Unifesp) said.
Anvisa authorized
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
